Senior Leadership Agenda

2026 ISPE Europe Annual Conference

Designed for executives shaping enterprise-wide transformation and industry-wide innovation strategies.

Your time is valuable and your decisions have enterprise-wide impact. This agenda cuts straight to sessions featuring strategic perspectives on AI governance, global regulatory harmonization, and first-of-kind implementations that are reshaping competitive advantage in pharma.

Every recommendation addresses the questions you're asking in boardrooms and strategy sessions: How do we position for regulatory changes? Where should we place our digital transformation bets? What are industry leaders doing that we should know about?

This agenda includes decision-making guidance for every time slot, so you'll know exactly why each session matters to your role and goals.

Monday Schedule

TimeSessionType
0730 – 1745Registration OpenRegistration
0830 – 1200
Opening General Sessions
  • Welcome to the 2026 ISPE Europe Annual Conference
  • Leadership in a Changing World – Lars Fruergaard Jørgensen, Healthcare Denmark
  • Responding from Every Seat – Susanne Hundsbaek-Pedersen, Roche
  • A Word from the ISPE Vice President – Thomas Zimmer
  • Reimagining Regulatory Operations in the AI Age – EMA Perspective
  • FOYA Category Winners Announcement
  • Message from the Conference Chair – David Estape
C-suite perspectives on industry direction and regulatory evolution - essential strategic context
General Session
0945 – 1900Exhibition Area OpenNetworking
1000 – 1045Networking Break in the Exhibition AreaNetworking
1200 – 1330Networking Lunch in the Exhibition AreaMeal/Networking
1330 – 1500
Choose Your Focus:

Option A: Quality Risk Management in the Light of New European Pharma Regulations

Choose this if driving enterprise QRM transformation or preparing for new EU regulations

Option B: Building a Sustainability Culture in Life Sciences Companies

Choose this if setting organizational sustainability strategy and culture

Option C: GEP & GMP Compliant Project Delivery

Choose this if overseeing major capital programs or facility expansions

Option D: Pharma Open Data Space: Turning Vision into Reality

Choose this if exploring industry-wide data collaboration opportunities

Option E: Drug Shortages Prevention

Choose this if responsible for enterprise supply chain strategy
Interactive Forums
1500 – 1545Networking Break in the Exhibition AreaNetworking
1545 – 1615

KEY SESSION: Architecting Compliance: GxP for the AI Era
Shruti Mukherjee, GlobalVision

Deep dive into Compliance-by-Design frameworks for AI systems - essential for digital transformation governance
Digital Compliance
1615 – 1645

KEY SESSION: The Dual Challenge: Data Security & AI Use for GxP Apps
Arun Parekkat (RiskCortex) & John Patterson (Centenarian Technologies)

Advanced case study on dual risk mitigation - Expert-in-the-Loop approaches for enterprise AI deployment
Digital Compliance
1645 – 1715

KEY SESSION: ICH Guideline Interpretation and PACs Regulatory Strategy
Karim Kacimi, NovoNordisk

Expert analysis of divergent ICH interpretations across regions - strategic insights for global regulatory planning
Regulatory and Quality
1715 – 1900Welcome Reception in the Exhibition AreaNetworking

Tuesday Schedule

TimeSessionType
0730 – 1730Registration OpenRegistration
0830 – 0945
Opening General Sessions
  • Day 2 Opening Remarks – Mike Martin, ISPE
  • Industrializing Biopharma: How AI and Modularization Can Close the Global Access Gap – Lars Petersen, FUJIFILM Biotechnologies
  • Keynote Presentation
Strategic vision for biopharma industrialization and global access
General Session
0945 – 1030Networking Break in the Exhibition AreaNetworking
0945 – 1600Exhibition Area OpenNetworking
1030 – 1100

KEY SESSION: Advanced Digitalization in Personalized Medicine
Pravina Sail, Cipla

Strategic blueprint for patient-specific manufacturing operations - integration patterns without "rip-and-replace"
Pharma 4.0™ in Action
1100 – 1130

KEY SESSION: Managing the Nitrosamines Risk in Pharma
Alessandro Viola, IPS-Integrated Project Services

Deep scientific and regulatory analysis - advanced risk assessment and long-term prevention strategies
Sustainability & Substances of Concern
1130 – 1200

KEY SESSION: First Commercial MTP-based Modular Plant in GMP Environment
Sebastian Härtner (Merck KGaA) & Thomas Makait (MTP4Pharma®)

World-first implementation case study - advanced insights on integrated CSV and data-driven engineering for modular manufacturing
Pharma 4.0™ in Action
1200 – 1330Networking Lunch in the Exhibition AreaMeal/Networking
1330 – 1400

RECOMMENDED: Implementing Data Integrity: Real-World Lessons
Anna Dachs Soler & Francesc Garrido, AMBIT Iberia

Large-scale DI program preparing for FDA inspection - battle-tested governance and cultural change strategies
Digital Compliance
1400 – 1430

KEY SESSION: Audit Trails: Practical Approaches to Data Integrity
Philip Hörsch (Vetter Pharma) & Kerstin Kruithoff-Ley (CirQum)

Advanced audit trail management aligned with revised Annex 11 draft - expert guidance on configuration and retention
Digital Compliance
1430 – 1500

RECOMMENDED: Sustainability Through Optimization of CIP Processes
Paddy MacGabhann, Hyde Engineering and Consulting

Advanced CIP optimization case studies with quantified sustainability impact - substantial productivity improvements
Sustainability & Substances of Concern
1500 – 1545Networking Break in the Exhibition AreaNetworking
1545 – 1700
Closing General Sessions
  • Day 2 Conference Highlights – David Estape, CRB Group GmbH
  • Keynote Presentation
  • Keynote Presentation – Syed Abbas Yar-Khan, Eli Lilly and Company
General Session
1900 – 2300
Networking Dinner
Executive networking opportunity - connect with industry peers and potential partners
Networking

Wednesday Schedule

TimeSessionType
0730 – 1700Registration OpenRegistration
0830 – 1015
Opening General Sessions
  • Day 3 Opening Remarks
  • ISPE Affiliate Insights – Anders Widov, BWT Pharma & Biotech AB
  • Pharma 4.0™ Survey Results
  • Women in Pharma® Supported Presentation
Industry benchmark data for strategic planning and organizational comparison
General Session
0945 – 1400Exhibition Area OpenNetworking
1015 – 1100Networking Break in the Exhibition AreaNetworking
1100 – 1130

KEY SESSION: Delivering Innovation via the Dossier of the Future
Monica Perea Velez, GSK

Expert analysis of ICH M4(Q) revision and SPQS implications - generative AI for CMC submissions and new EU GPL Annex
Regulatory and Quality
1130 – 1200

KEY SESSION: CMC Structured Submissions in the Cloud with AI

ISPE Project PRISM CMC use case - collaborative review platforms and AI-enabled structured submissions
Regulatory and Quality
1200 – 1230

KEY SESSION: The Continuing Challenge of LCM in a Global Landscape
Stuart Finnie, Gilead Sciences

Expert industry and agency perspectives on lifecycle management - advanced strategies for global harmonization
Regulatory and Quality
1230 – 1400Networking Lunch in the Exhibition AreaMeal/Networking
1400 – 1630
Closing General Sessions
  • General Session
  • General Session – Tala Fakhouri, PhD, MPH, Parexel International
  • Regulatory Panel Discussion
  • Closing Remarks
Regulatory panel with agency perspectives - critical for strategic planning and compliance positioning
General Session